Artificial Intelligence-Enhanced Dual-Modal Fluorescence Lifetime Imaging-Optical Coherence Tomography in Patients with Coronary Artery Disease
Presenter:
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Equity/Stock(s)/Options - Dotter
- Royalty/Intellectual Property Rights - Dotter